John Hazlin's most recent trade in Colgate-Palmolive Co. was a trade of 27,042 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Colgate-Palmolive | Mr. John Hazlin | Chief Growth Officer | 16 Sep 2026 | 27,042 | 27,042 | - | - | Stock Option (Right to Buy) | ||
| Colgate-Palmolive | Mr. John Hazlin | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2026 | 3,908 | 27,021 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive | Mr. John Hazlin | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.80 per share. | 11 Sep 2026 | 649 | 24,051 (0%) | 0% | 86.8 | 56,333 | Common Stock |
| Colgate-Palmolive | Mr. John Hazlin | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.80 per share. | 11 Sep 2026 | 499 | 23,113 (0%) | 0% | 86.8 | 43,313 | Common Stock |
| Colgate-Palmolive | Mr. John Hazlin | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.80 per share. | 11 Sep 2026 | 439 | 23,612 (0%) | 0% | 86.8 | 38,105 | Common Stock |
| Colgate-Palmolive | Mr. John Hazlin | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2026 | 12,803 | 30,539 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive | Mr. John Hazlin | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.10 per share. | 23 Feb 2026 | 6,117 | 24,422 (0%) | 0% | 97.1 | 593,961 | Common Stock |
| Colgate-Palmolive | Mr. John Hazlin | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 76.41 per share. | 10 Feb 2026 | 20,989 | 38,634 (0%) | 0% | 76.4 | 1,603,769 | Common Stock |
| Colgate-Palmolive | Mr. John Hazlin | Chief Growth Officer | 10 Feb 2026 | 20,989 | 0 | - | - | Stock Option (Right to Buy) | ||
| Colgate-Palmolive | Mr. John Hazlin | Chief Growth Officer | Sale of securities on an exchange or to another person at price $ 94.25 per share. | 10 Feb 2026 | 20,989 | 17,645 (0%) | 0% | 94.2 | 1,978,211 | Common Stock |
| Colgate-Palmolive | Mr. John Hazlin | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.20 per share. | 03 Dec 2025 | 156 | 17,645 (0%) | 0% | 78.2 | 12,199 | Common Stock |
| Colgate-Palmolive | Mr. John Hazlin | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.28 per share. | 12 Sep 2025 | 449 | 17,629 (0%) | 0% | 83.3 | 37,393 | Common Stock |
| Colgate-Palmolive | Mr. John Hazlin | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.28 per share. | 12 Sep 2025 | 377 | 18,078 (0%) | 0% | 83.3 | 31,397 | Common Stock |
| Colgate-Palmolive | Mr. John Hazlin | Chief Growth Officer | 11 Sep 2025 | 28,007 | 28,007 | - | - | Stock Option (Right to Buy) | ||
| Colgate-Palmolive | Mr. John Hazlin | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2025 | 4,045 | 18,455 (0%) | 0% | 0 | Common Stock |